organization · Reporting owner
Medpace Investors, LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Medpace Holdings, Inc.MEDP · Entity 3327 | 10% owner | March 06, 2024 | March 08, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Medpace Holdings, Inc.
Report date March 06, 2024 · Filed March 08, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,733,019 |
Ending reported balance
After 2024-03-08 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2024-03-06 · Sale · Disposed 100,000 · Balance 4,833,019 F1: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F2: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $406.36 to $419.42. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. Row 2 · 2024-03-07 · Sale · Disposed 75,000 · Balance 4,758,019 F1: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F3: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $406.33 to $415.64. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. Row 3 · 2024-03-08 · Sale · Disposed 25,000 · Balance 4,733,019 F1: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F4: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $402.90 to $414.195. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.
F2: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $406.36 to $419.42. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
F3: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $406.33 to $415.64. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
F4: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $402.90 to $414.195. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 19, 2021 Filed Jul 20, 2021 20:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 1,442 | $181.11 | $261,160.62 |
DisclosureSEC source: 0001567619-21-013713 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,137,519 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $182.235. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 16, 2021 Filed Jul 20, 2021 20:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 12,454 | $182.83 | $2,276,964.82 |
DisclosureSEC source: 0001567619-21-013713 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,138,961 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.605 to $184.48. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 20:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 13,697 | $181.88 | $2,491,210.36 |
DisclosureSEC source: 0001567619-21-013573 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,151,415 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.38 to $183.34. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 14, 2021 Filed Jul 16, 2021 20:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 11,026 | $182.63 | $2,013,678.38 |
DisclosureSEC source: 0001567619-21-013573 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,165,112 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $181.655 to $184.18. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 13, 2021 Filed Jul 14, 2021 20:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 13,050 | $182.96 | $2,387,628.00 |
DisclosureSEC source: 0001567619-21-013376 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,176,138 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $181.325 to $184.59. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 20:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 10,540 | $183.22 | $1,931,138.80 |
DisclosureSEC source: 0001567619-21-013376 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,189,188 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.715 to $184.76. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 09, 2021 Filed Jul 12, 2021 20:18 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 12,597 | $183.34 | $2,309,533.98 |
DisclosureSEC source: 0001567619-21-013234 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,199,728 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.595 to $184.98. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 08, 2021 Filed Jul 12, 2021 20:18 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 3,951 | $180.18 | $711,891.18 |
DisclosureSEC source: 0001567619-21-013234 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,212,325 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $180.72. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 07, 2021 Filed Jul 8, 2021 20:17 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 4,574 | $180.33 | $824,829.42 |
DisclosureSEC source: 0001567619-21-013139 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,216,276 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $180.905. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 20:17 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 4,729 | $180.58 | $853,962.82 |
DisclosureSEC source: 0001567619-21-013139 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,220,850 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $181.28. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 02, 2021 Filed Jul 6, 2021 20:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 3,556 | $180.16 | $640,648.96 |
DisclosureSEC source: 0001567619-21-013005 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,225,579 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $180.50. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 20:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 238 | $180.03 | $42,847.14 |
DisclosureSEC source: 0001567619-21-013005 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,229,135 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $180.20. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| June 29, 2021 Filed Jul 1, 2021 20:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 4,926 | $181.11 | $892,147.86 |
DisclosureSEC source: 0001567619-21-012834 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,229,373 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $182.395. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| June 28, 2021 Filed Jun 29, 2021 20:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 8,225 | $181.15 | $1,489,958.75 |
DisclosureSEC source: 0001567619-21-012696 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,234,299 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $182.265. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| June 25, 2021 Filed Jun 29, 2021 20:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 10,846 | $180.56 | $1,958,353.76 |
DisclosureSEC source: 0001567619-21-012696 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,242,524 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $181.505. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| June 23, 2021 Filed Jun 25, 2021 20:17 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 1,837 | $180.79 | $332,111.23 |
DisclosureSEC source: 0001567619-21-012620 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,253,370 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $182.87. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 20:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 12,133 | $182.31 | $2,211,967.23 |
DisclosureSEC source: 0001567619-21-012512 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,255,207 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $181.21 to $183.99. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 20:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 9,345 | $181.86 | $1,699,481.70 |
DisclosureSEC source: 0001567619-21-012512 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,267,340 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.035 to $182.76. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| June 18, 2021 Filed Jun 21, 2021 20:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 1,261 | $180.43 | $227,522.23 |
DisclosureSEC source: 0001567619-21-012433 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,276,685 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $181.97. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 20:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 8,927 | $181.20 | $1,617,572.40 |
DisclosureSEC source: 0001567619-21-012433 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,277,946 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $182.405. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 20:17 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 17,413 | $181.13 | $3,154,016.69 |
DisclosureSEC source: 0001567619-21-012321 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,286,873 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $182.685. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 20:17 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 15,706 | $182.00 | $2,858,492.00 |
DisclosureSEC source: 0001567619-21-012321 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,304,286 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $183.20. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| April 26, 2021 Filed Apr 27, 2021 20:24 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 20,729 | $193.38 | $4,008,574.02 |
DisclosureSEC source: 0001567619-21-008644 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,319,992 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $188.54 to $195.87. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| April 23, 2021 Filed Apr 27, 2021 20:24 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 7,805 | $190.51 | $1,486,930.55 |
DisclosureSEC source: 0001567619-21-008644 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,340,721 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $187.515 to $191.705. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| April 22, 2021 Filed Apr 23, 2021 20:22 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 14,377 | $188.64 | $2,712,077.28 |
DisclosureSEC source: 0001567619-21-008541 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,348,526 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $185.25 to $191.62. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| April 21, 2021 Filed Apr 23, 2021 20:22 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 15,687 | $187.02 | $2,933,782.74 |
DisclosureSEC source: 0001567619-21-008541 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,362,903 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $182.95 to $189.39. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| April 20, 2021 Filed Apr 21, 2021 20:10 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 17,623 | $182.44 | $3,215,140.12 |
DisclosureSEC source: 0001567619-21-008414 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,378,590 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $185.35. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| April 19, 2021 Filed Apr 21, 2021 20:10 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 8,471 | $180.90 | $1,532,403.90 |
DisclosureSEC source: 0001567619-21-008414 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,396,213 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $183.57. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| April 16, 2021 Filed Apr 16, 2021 23:28 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 17,528 | $180.30 | $3,160,298.40 |
DisclosureSEC source: 0000899243-21-016136 · doc4.xml · nonDerivative · entry 3 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,404,684 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $184.91. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 23:28 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 31,270 | $186.65 | $5,836,545.50 |
DisclosureSEC source: 0000899243-21-016136 · doc4.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,422,212 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.045 to $190.60. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| April 14, 2021 Filed Apr 16, 2021 23:28 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 3,720 | $180.48 | $671,385.60 |
DisclosureSEC source: 0000899243-21-016136 · doc4.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,453,482 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $181.55. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| January 08, 2021 Filed Jan 11, 2021 21:22 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 26,666 | $140.71 | $3,752,172.86 |
DisclosureSEC source: 0001567619-21-000860 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,457,202 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $140.00 to $142.29. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 21:06 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 93,552 | $140.06 | $13,102,893.12 |
DisclosureSEC source: 0001567619-21-000814 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,483,868 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $140.00 to $141.425. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:08 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 11,112 | $0.00 Strike: $18.23 | $0.00 |
DisclosureSEC source: 0001567619-21-000724 · doc1.xml · derivative · entry 10 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,112 shares Expires 2023-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:08 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,887 | $0.00 Strike: $16.88 | $0.00 |
DisclosureSEC source: 0001567619-21-000724 · doc1.xml · derivative · entry 9 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,887 shares Expires 2022-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:08 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 65,305 | $0.00 Strike: $16.20 | $0.00 |
DisclosureSEC source: 0001567619-21-000724 · doc1.xml · derivative · entry 8 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 65,305 shares Expires 2022-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:08 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,925 | $0.00 Strike: $14.41 | $0.00 |
DisclosureSEC source: 0001567619-21-000724 · doc1.xml · derivative · entry 7 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,925 shares Expires 2021-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:08 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 92,118 | $0.00 Strike: $14.41 | $0.00 |
DisclosureSEC source: 0001567619-21-000724 · doc1.xml · derivative · entry 6 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 92,118 shares Expires 2021-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:08 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 11,112 | $18.23 | $202,571.76 |
DisclosureSEC source: 0001567619-21-000724 · doc1.xml · nonDerivative · entry 5 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,669,087 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:08 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 10,887 | $16.88 | $183,772.56 |
DisclosureSEC source: 0001567619-21-000724 · doc1.xml · nonDerivative · entry 4 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,657,975 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:08 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 65,305 | $16.20 | $1,057,941.00 |
DisclosureSEC source: 0001567619-21-000724 · doc1.xml · nonDerivative · entry 3 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,647,088 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:08 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 5,925 | $14.41 | $85,379.25 |
DisclosureSEC source: 0001567619-21-000724 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,581,783 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2021 Filed Jan 7, 2021 21:08 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 92,118 | $14.41 | $1,327,420.38 |
DisclosureSEC source: 0001567619-21-000724 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,575,858 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2021 Filed Jan 8, 2021 21:06 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 91,667 | $140.06 | $12,838,880.02 |
DisclosureSEC source: 0001567619-21-000814 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,577,420 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $140.00 to $141.01. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:08 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 10,127 | $140.01 | $1,417,881.27 |
DisclosureSEC source: 0001567619-21-000498 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,483,740 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $140.00 to $140.29. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| December 30, 2020 Filed Dec 31, 2020 19:33 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 19,930 | $140.01 | $2,790,399.30 |
DisclosureSEC source: 0001567619-20-021750 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,493,867 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $140.00 to $140.28. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| December 28, 2020 Filed Dec 29, 2020 21:06 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 1,374 | $140.00 | $192,360.00 |
DisclosureSEC source: 0001567619-20-021629 · doc1.xml · nonDerivative · entry 3 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,513,797 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. Read SEC document |
| December 24, 2020 Filed Dec 29, 2020 21:06 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 3,829 | $140.00 | $536,060.00 |
DisclosureSEC source: 0001567619-20-021629 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,515,171 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. Read SEC document |
| December 23, 2020 Filed Dec 29, 2020 21:06 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 3,547 | $140.11 | $496,970.17 |
DisclosureSEC source: 0001567619-20-021629 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,519,000 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $140.00 to $141.00. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| December 22, 2020 Filed Dec 23, 2020 21:05 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 33,260 | $140.01 | $4,656,732.60 |
DisclosureSEC source: 0000899243-20-034976 · doc4.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,522,547 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $140.00 to $140.295. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.